X
No Ads. No Trackers. No Kidding! (Learn More)
Loading...
Government officials said Wednesday afternoon they are "distressed" about the rising number of COVID-19 cases in the U.S., with one official noting that 75%... [Read More]
Even within same-party families, there is debate about how long it will take to get the U.S. out of the COVID-19 pandemic. [Read More]
Thumbnail
This interview is part of a series of conversations MarketWatch is conducting with some of the leading voices in the U.S. on the COVID-19 pandemic.... [Read More]
Shares of Biogen undefined were down 0.1% in premarket trading on Wednesday after the company missed earnings expectations for the quarter. The drug maker... [Read More]
Shares of CVS Health Corp. undefined gained 0.6% in premarket trading on Monday after the retail giant announced plans to hire 15,000 full-time and part-time... [Read More]
Shares of CVS Health Corp. CVS, +0.45% ... [Read More]
The Trump administration this week promoted a theory that calls for people at low risk of contracting COVID-19 to return to schools, sports, and the... [Read More]
The Trump administration this week promoted a theory that calls for people at low risk of contracting COVID-19 to return to schools, sports, and the... [Read More]
Thumbnail
The Trump administration this week promoted a theory that calls for people at low risk of contracting COVID-19 to return to schools, sports, and the... [Read More]
The Trump administration this week promoted a theory that calls for people at low risk of contracting COVID-19 to return to schools, sports, and the... [Read More]
A clinical trial conducted by the World Health Organization found that Gilead Sciences Inc.'s remdesivir, hydroxychloroquine, AbbVie's undefined... [Read More]
A clinical trial reportedly found that Gilead Sciences Inc.'s undefined COVID-19 treatment remdesivir had no impact on survival in patients with the... [Read More]
Shares of Vertex Pharmaceuticals Inc. undefined were down 9.8% in premarket trading on Thursday, the day after the drug maker said it had stopped development... [Read More]
Loading...
Save As
Preview
Preview